CytomX Therapeutics
CTMX
#9714
Rank
NZ$65.2 M
Marketcap
$0.81
Share price
-16.11%
Change (1 day)
-76.18%
Change (1 year)

Market capitalization of CytomX Therapeutics (CTMX)

Market cap: NZ$65.2 Million

As of April 2025 CytomX Therapeutics has a market cap of NZ$65.2 Million. This makes CytomX Therapeutics the world's 9714th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CytomX Therapeutics from 2015 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$65.2 M-56.09%
2024NZ$0.14 B-9.57%
2023NZ$0.16 B-1.41%
2022NZ$0.16 B-59.74%
2021NZ$0.41 B-5.57%
2020NZ$0.43 B-22.02%
2019NZ$0.56 B-44.65%
2018NZ$1.01 B-11.1%
2017NZ$1.14 B97.67%
2016NZ$0.57 B-47.44%
2015NZ$1.09 B

End of Day market cap according to different sources

On Apr 4th, 2025 the market cap of CytomX Therapeutics was reported to be:

NZ$65.2 Million
by Nasdaq info icon info icon
NZ$65.2 Million
by CompaniesMarketCap info icon info icon
NZ$65.2 Million
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.61 B 849.79%๐Ÿ‡บ๐Ÿ‡ธ USA